Psychotropics and Hepatic Issues: Nonalcoholic Fatty Liver Disease
How important are ALT and AST abnormalities when prescribing psychotropics? Should you adjust dosing in patients with elevated ALT and AST? Does inflammation alter drug kinetics?
Faculty: Jonathan Meyer, M.D.
Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.
